Home › Essential Thrombocythemia › North Carolina › Winston-Salem
Essential Thrombocythemia clinical trials in Winston-Salem, NC
3 studies for Essential Thrombocythemia are looking for participants at sites in and around Winston-Salem (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
RecruitingPhase 2
- Wake Forest University Health Sciences, Winston-Salem
A Study to Evaluate DMR-001 in Participants With CALR-mutant Myeloproliferative Neoplasms
RecruitingPhase 1
- Site US13, Winston-Salem
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
RecruitingPhase 1
- Wake Forest Baptist Medical Center, Winston-Salem
Essential Thrombocythemia trials in other cities
- New York City, NY8 studies
- Durham, NC7 studies
- Nashville, TN5 studies
- Salt Lake City, UT5 studies
- Boston, MA5 studies
- Baltimore, MD5 studies
- Mountain View, CA4 studies
- Irvine, CA4 studies
- Columbus, OH4 studies
- Miami, FL4 studies
- Chicago, IL4 studies
- Houston, TX4 studies
Other studies in Winston-Salem
- Acute Myeloid Leukemia20 studies
- Cancer (all types)19 studies
- Multiple Myeloma16 studies
- Breast Cancer15 studies
- Cardiovascular Disease13 studies
- Non-Small Cell Lung Cancer11 studies
- COPD11 studies
- Ovarian Cancer10 studies
- Myeloproliferative Neoplasms9 studies
- Myelofibrosis9 studies
- Type 2 Diabetes9 studies
- Myelodysplastic Syndromes9 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.